Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Esophageal Squamous Cell Carcinoma × apatinib × Clear all

Phase

Status

Sponsor Class

OTHER 9 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 2 Breast Neoplasms 2 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 2 nedaplatin 1 durvalumab 1 camrelizumab 1 apatinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Paclitaxel 1 Irinotecan 1 Drug Therapy 1 Capecitabine 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03603756 2020-02-11

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

ChineseAMS

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡